Why This Matters
Early detection changes everything.
Ovarian cancer can happen to any woman. It is one of the hardest cancers to catch early — but when it is caught early, it saves lives.
93%
5-year survival rate when ovarian cancer is caught early.
1 in 91
women will be diagnosed with ovarian cancer in her lifetime.
1/5
Funding for women’s health research is one-fifth that of men’s health.
Statistics shown are working figures pending confirmation with TGen before publishing.
The research we are funding
The Ovarian Cancer Screening & Early Detection Initiative
Early detection of ovarian cancer has been nearly impossible: initial symptoms like bloating and abdominal pain are easy to miss or dismiss, and the standard screening tools aren’t sensitive enough to flag the disease before it progresses.
TGen researchers have identified unique biological signatures in standard Pap smears and blood that can reliably distinguish ovarian cancer patients from healthy individuals.
Philanthropic funding from the Lynne Trobaugh Golf Classic will expand the clinical trial of this Pap smear and blood test, reaching more patients across Arizona and the Southwest — validating those unique signatures to detect cancer at its earliest and most treatable stage, for both initial diagnoses and relapses.
If these trials prove successful, ovarian cancer could be detected with the same Pap smear a woman already gets at her annual exam — something that hasn’t been done before — reaching women early enough to be treated effectively and allowing them to continue living their lives to the fullest.
This description is a working summary pending TGen’s official program language.
Help fund the breakthrough
Every dollar raised supports this research. Join us on October 2nd, or give directly to TGen.